NSAM
TMO icon

North Star Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

North Star Asset Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.3M Sell
61,741
-8
-0% -$4.34K 1.32% 20
2025
Q4 		$35.8M Sell
61,749
-305
-0.5% -$172K 1.44% 15
2025
Q3 		$30.1M Buy
62,054
+1,491
+2% +$694K 1.22% 27
2025
Q2 		$24.6M Buy
60,563
+3,824
+7% +$1.6M 1.04% 32
2025
Q1 		$28.2M Buy
56,739
+1,114
+2% +$603K 1.29% 22
2024
Q4 		$28.9M Buy
55,625
+1,581
+3% +$869K 1.28% 20
2024
Q3 		$33.4M Sell
54,044
-139
-0.3% -$82.3K 1.5% 16
2024
Q2 		$30M Buy
54,183
+317
+0.6% +$182K 1.42% 19
2024
Q1 		$31.3M Buy
53,866
+250
+0.5% +$140K 1.48% 19
2023
Q4 		$28.5M Buy
53,616
+1,006
+2% +$487K 1.46% 19
2023
Q3 		$26.6M Buy
52,610
+830
+2% +$442K 1.53% 17
2023
Q2 		$27M Buy
51,780
+819
+2% +$442K 1.49% 16
2023
Q1 		$29.4M Sell
50,961
-312
-0.6% -$176K 1.73% 10
2022
Q4 		$28.2M Sell
51,273
-57
-0.1% -$30.2K 1.75% 12
2022
Q3 		$26M Buy
51,330
+1,536
+3% +$860K 1.78% 9
2022
Q2 		$27.1M Sell
49,794
-304
-0.6% -$167K 1.78% 12
2022
Q1 		$29.6M Sell
50,098
-971
-2% -$558K 1.63% 14
2021
Q4 		$34.1M Sell
51,069
-908
-2% -$567K 1.71% 11
2021
Q3 		$29.7M Sell
51,977
-24
-0% -$13.2K 1.63% 14
2021
Q2 		$26.2M Buy
52,001
+2,276
+5% +$1.07M 1.45% 20
2021
Q1 		$22.7M Buy
49,725
+193
+0.4% +$92.1K 1.36% 20
2020
Q4 		$23.1M Sell
49,532
-807
-2% -$378K 1.46% 17
2020
Q3 		$22.2M Sell
50,339
-847
-2% -$350K 1.64% 15
2020
Q2 		$18.5M Sell
51,186
-2,781
-5% -$932K 1.47% 16
2020
Q1 		$15.3M Buy
53,967
+981
+2% +$309K 1.48% 17
2019
Q4 		$17.2M Sell
52,986
-460
-0.9% -$139K 1.24% 22
2019
Q3 		$15.6M Buy
53,446
+174
+0.3% +$49.8K 1.22% 25
2019
Q2 		$15.6M Buy
53,272
+479
+0.9% +$132K 1.22% 28
2019
Q1 		$14.4M Buy
52,793
+127
+0.2% +$31.6K 1.17% 29
2018
Q4 		$11.8M Buy
52,666
+634
+1% +$149K 1.12% 32
2018
Q3 		$12.7M Buy
52,032
+777
+2% +$179K 1.02% 34
2018
Q2 		$10.6M Buy
51,255
+2,215
+5% +$470K 0.91% 39
2018
Q1 		$10.1M Buy
49,040
+1,007
+2% +$211K 0.91% 39
2017
Q4 		$9.12M Buy
48,033
+1,091
+2% +$209K 0.82% 43
2017
Q3 		$8.88M Sell
46,942
-503
-1% -$91.1K 0.88% 40
2017
Q2 		$8.28M Sell
47,445
-1,126
-2% -$189K 0.84% 43
2017
Q1 		$7.46M Buy
48,571
+1,932
+4% +$295K 0.79% 49
2016
Q4 		$6.58M Buy
46,639
+1,675
+4% +$247K 0.72% 56
2016
Q3 		$7.15M Sell
44,964
-828
-2% -$128K 0.81% 47
2016
Q2 		$6.77M Buy
45,792
+435
+1% +$64.2K 0.79% 50
2016
Q1 		$6.42M Buy
45,357
+643
+1% +$86.2K 0.75% 53
2015
Q4 		$6.34M Buy
44,714
+1,482
+3% +$198K 0.76% 48
2015
Q3 		$5.29M Buy
43,232
+5,153
+14% +$671K 0.66% 55
2015
Q2 		$4.94M Buy
38,079
+397
+1% +$51.8K 0.56% 65
2015
Q1 		$5.06M Buy
37,682
+813
+2% +$105K 0.57% 65
2014
Q4 		$4.62M Buy
36,869
+940
+3% +$114K 0.53% 77
2014
Q3 		$4.37M Buy
35,929
+193
+0.5% +$23.5K 0.52% 75
2014
Q2 		$4.22M Sell
35,736
-418
-1% -$49.2K 0.49% 76
2014
Q1 		$4.35M Buy
36,154
+888
+3% +$106K 0.52% 71
2013
Q4 		$3.93M Buy
35,266
+970
+3% +$96.5K 0.48% 77
2013
Q3 		$3.16M Buy
+34,296
New +$3.1M 0.41% 87

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

North Star Asset Management's TMO Position: Q1 2026 in Review

North Star Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 0.01% in Q1 2026, selling an estimated $4.34K and leaving 61,741 shares worth $30.3M. The position accounts for 1.32% of the portfolio, ranked #20.

North Star Asset Management first reported a position in TMO in Q3 2013 and has held it in 51 quarters since. The position peaked at $35.8M in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • North Star Asset Management held 61,741 shares of Thermo Fisher Scientific worth $30.3M as of Q1 2026.
  • North Star Asset Management sold 8 Thermo Fisher Scientific shares in Q1 2026, an estimated $4.34K.
  • Thermo Fisher Scientific made up 1.32% of North Star Asset Management's portfolio in Q1 2026, its #20 holding.
  • North Star Asset Management first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 51 quarters since.
  • North Star Asset Management's Thermo Fisher Scientific position peaked at $35.8M in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on North Star Asset Management's 13F filing for Q1 2026, filed 6 May 2026.